How to continue to deliver high-quality healthcare products when rising life expectancy is straining health systems across Europe?

Across Europe, the continuous increase in life expectancy is resulting in an ever larger ageing population.  Although this is should be seen as very positive, it does raise some concerns in relation to all European healthcare systems. Indeed, as the population ages  the risk of chronic cardiac disease increases (such as the coronary artery disease bradycardia), and healthcare systems struggle to face this increasing demand due to flat or decreasing budgets.

Notwithstanding this budgetary pressure, medical treatment is continually progressing by offering more advanced and more expensive therapies. Today’s healthcare environment sees very few medical innovations that are targeted towards reducing costs for treating specific diseases.

As with most successful innovations over recent years, real advantages do not arise from lifting product features to the functional maximum, but from combining existing technologies and services to create smart and sustainable solutions for all relevant players in the system. NayaMed represents such a solution which goes beyond outdated categories such as “the best features” or “the cheapest price”.